News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,010 Results
Type
Article (87310)
Company Profile (759)
Press Release (770914)
Multimedia
Podcasts (166)
Webinars (27)
Section
Business (233003)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91223)
Employer Resources (202)
FDA (18262)
Job Trends (17392)
News (397272)
Policy (39910)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (139)
Alzheimer's disease (1661)
Antibody-drug conjugate (ADC) (211)
Approvals (18266)
Artificial intelligence (466)
Autoimmune disease (53)
Automation (24)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (155)
Biotechnology (484)
Bladder cancer (120)
Brain cancer (47)
Breast cancer (454)
Cancer (3643)
Cardiovascular disease (322)
Career advice (3552)
Career pathing (36)
CAR-T (236)
CDC (52)
Cell therapy (644)
Cervical cancer (31)
Clinical research (75073)
Collaboration (1318)
Company closure (4)
Compensation (876)
Complete response letters (57)
COVID-19 (2946)
CRISPR (80)
C-suite (524)
Cystic fibrosis (130)
Data (3971)
Decentralized trials (2)
Denatured (59)
Depression (106)
Diabetes (438)
Diagnostics (7067)
Digital health (31)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (225)
Drug pricing (171)
Drug shortages (36)
Duchenne muscular dystrophy (188)
Earnings (98661)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132543)
Executive appointments (963)
FDA (20570)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1171)
Gene editing (167)
Generative AI (45)
Gene therapy (511)
GLP-1 (1005)
Government (5359)
Grass and pollen (7)
Guidances (334)
Healthcare (20937)
HIV (48)
Huntington's disease (35)
IgA nephropathy (54)
Immunology and inflammation (232)
Immuno-oncology (19)
Indications (50)
Infectious disease (3172)
Inflammatory bowel disease (180)
Inflation Reduction Act (14)
Influenza (89)
Intellectual property (175)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (73)
Layoffs (631)
Leadership (32)
Legal (10147)
Liver cancer (91)
Longevity (12)
Lung cancer (519)
Lymphoma (252)
Machine learning (25)
Management (66)
Manufacturing (593)
MASH (125)
Medical device (14843)
Medtech (14861)
Mergers & acquisitions (22696)
Metabolic disorders (1111)
Multiple sclerosis (132)
NASH (23)
Neurodegenerative disease (201)
Neuropsychiatric disorders (53)
Neuroscience (2615)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (549)
Opinion (305)
Ovarian cancer (122)
Pain (158)
Pancreatic cancer (156)
Parkinson's disease (223)
Partnered (28)
Patents (395)
Patient recruitment (279)
Peanut (57)
People (66112)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23142)
Phase II (32608)
Phase III (24532)
Pipeline (2550)
Policy (285)
Postmarket research (3554)
Preclinical (10449)
Press Release (72)
Prostate cancer (184)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (628)
Real estate (7418)
Recruiting (78)
Regulatory (27807)
Reports (64)
Research institute (2680)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (68)
Schizophrenia (123)
Series A (194)
Series B (145)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (97)
Tariffs (85)
The Weekly (105)
Vaccines (1020)
Venture capital (64)
Weight loss (384)
Women's health (57)
Worklife (21)
Date
Today (79)
Last 7 days (517)
Last 30 days (2315)
Last 365 days (33761)
2025 (24549)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50850)
Australia (8933)
California (9064)
Canada (2764)
China (859)
Colorado (383)
Connecticut (405)
Delaware (249)
Europe (116812)
Florida (1334)
Georgia (307)
Hawaii (3)
Idaho (67)
Illinois (793)
India (47)
Indiana (445)
Iowa (19)
Japan (286)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (75)
Maryland (1230)
Massachusetts (6815)
Michigan (302)
Minnesota (549)
Mississippi (4)
Missouri (114)
Montana (33)
Nebraska (26)
Nevada (105)
New Hampshire (76)
New Jersey (2509)
New Mexico (32)
New York (2475)
North Carolina (1376)
North Dakota (10)
Northern California (4044)
Ohio (285)
Oklahoma (19)
Oregon (50)
Pennsylvania (1890)
Puerto Rico (19)
Rhode Island (45)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3458)
Tennessee (145)
Texas (1414)
United States (33612)
Utah (270)
Virginia (240)
Washington D.C. (82)
Washington State (783)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
There are 859,010 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top-20 pharma company. Still, there are many prominent women in pharma that could someday break through again.
September 29, 2025
·
1 min read
·
Annalee Armstrong
Layoff Tracker
Heidelberg Cuts 75% of Staff After Missed Royalty Payment
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
September 29, 2025
·
206 min read
·
BioSpace Editorial Staff
Press Releases
BioMark Secures Key Patents in Asia’s Largest Markets for Early Lung Cancer Liquid Biopsy
Pioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets.
September 29, 2025
·
3 min read
Press Releases
Scryb Closes Oversubscribed Private Placement for over $1.4M
September 29, 2025
·
5 min read
C-suite
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
Chief Commerical Officer Luke Miels will replace outgoing GSK CEO Emma Walmsley at the U.K. pharma next year.
September 29, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Quantum BioPharma Announces Corporate Updates
September 29, 2025
·
5 min read
Press Releases
Tevard Biosciences Presents Data Showing Compelling Full-Length Protein Rescue with tRNA-based Treatment for Duchenne Muscular Dystrophy and Dilated Cardiomyopathy at the 2025 FEBS Special Meeting
September 29, 2025
·
1 min read
Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial
September 29, 2025
·
4 min read
Layoffs
Biogen Shuffles 20 Staff After Ending AAV Work
The AAV pullback comes amid Biogen’s aggressive cost-cutting campaign, which put some 1,000 jobs on the chopping block with the goal of generating $1 billion in savings by 2025.
September 29, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
New Confirmatory Study Hints at ‘Alignment’ Between Applied Therapeutics, FDA for Rare Disease Drug
Applied Therapeutics has yet to confirm whether the study, posted on Clinicaltrials.gov on Thursday, means it has indeed aligned with the FDA on govorestat’s development.
September 29, 2025
·
2 min read
·
Tristan Manalac
1 of 85,901
Next
